CalciMedica, Inc. (CALC) — Financial statements
Income statement, balance sheet, and cash flow for CalciMedica, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 0.52 | |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00↑100.0% | -0.52 | |
| Operating Expenses | ||||||
| R&D Expenses | 15↑5.2% | 14↓8.7% | 16↑89.9% | 8↓55.8% | 19 | |
| General & Administrative Expenses | 8↓18.9% | 10↓56.2% | 22↑280.2% | 6↓65.7% | 17 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 8↓18.9% | 10↓56.2% | 22↑280.2% | 6↓65.7% | 17 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00↑100.0% | -0.52 | |
| Operating Expenses | 23↓4.5% | 24↓36.4% | 38↑168.3% | 14↓59.9% | 35 | |
| Total Costs & Expenses | 23↓4.5% | 24↓36.4% | 38↑168.3% | 14↓60.5% | 36 | |
| Operating Results | ||||||
| Operating Income | -23↑4.5% | -24↑36.4% | -38↓168.3% | -14↑60.5% | -36 | |
| Depreciation & Amortization | 0.05↓20.7% | 0.06↑0.0% | 0.06↑11.5% | 0.05↓90.0% | 0.52 | |
| EBITDA | -28↓16.4% | -24↑36.5% | -38↓397.6% | -8↑78.4% | -35 | |
| EBIT | -28↓16.3% | -24↑36.4% | -38↓395.0% | -8↑78.5% | -36 | |
| Interest & Other Income | ||||||
| Net Interest Income | -0.71 | 0.00↑100.0% | -0.11↑16.7% | -0.13 | 0.00 | |
| Interest Income | 0.71 | 0.00 | 0.00 | 0.00↓100.0% | 0.13 | |
| Interest Expense | 1 | 0.00↓100.0% | 0.11↓16.7% | 0.13↑4.8% | 0.13 | |
| Non-Operating Income | 5 | 0.00 | 0.00↑100.0% | -7↓5059.5% | -0.13 | |
| Other Income / Expenses | -6↓161.3% | 11↑182.5% | 4↓41.6% | 6↑4954.8% | 0.13 | |
| Income Before Tax | -30↓115.8% | -14↑60.1% | -34↓339.1% | -8↑78.2% | -36 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -30↓115.8% | -14↑60.1% | -34↓339.1% | -8↑78.2% | -36 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -30↓115.8% | -14↑60.1% | -34↓339.1% | -8↑78.2% | -36 | |
| Bottom-Line Net Income | -30↓115.8% | -14↑60.1% | -34↓275.8% | -9↑74.5% | -36 | |
| EPS (Basic) | -1.97↓61.5% | -1.22↑84.1% | -7.65↑67.0% | -23.20↑1.9% | -23.66 | |
| EPS (Diluted) | -1.97↓61.5% | -1.22↑84.1% | -7.65↑67.0% | -23.20↑1.9% | -23.66 | |
| Weighted Average Shares | 15,011↑133382.4% | 11↑150.5% | 4↑192.5% | 2↑1.4% | 2 | |
| Weighted Average Diluted Shares | 15,011↑133382.4% | 11↑150.5% | 4↑192.5% | 2↑1.4% | 2 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.